MSB mesoblast limited

1.85%

$1.65

Ann: Ryoncil Highlighted at Tandem Transplantation Meetings, page-31

First 31 Last

Share
Profile

Follow
GRolla247

254 Posts.

14

14/02/25

14:30

Post #: 77860771
Share

Originally posted by JuliusCoolius: ↑

Am I the only one who is disappointed that two months after an FDA approval the company is still talking about an upcoming launch of the product?

Based on the standard FDA process and the feedback they received, they should have known that an FDA approval was coming. They also talked extensively about the discussions they were having with payers, and with transplant clinic. They talked about positioning inventory ahead of launch (inventory already made). They talked about hiring senior leader to handle the launch.

So what's been the hold up? Have they been providing the treatment free of charge in the last two months? Have they been turning away potential patients because they haven't got everything figured out?

I am all for talking up their presence at the conference. I think their presence will be instrumental to getting OFF LABEL use especially for adults. But a lot of the PR seems to suggest they are doing an introduction of the product. I imagine this conference was part of their launch plan, but it just feels that there isn't much happening, when we should be far along by now.

I like to call a spade a spade, and right not I am not impressed with the slow progress.

What are the thoughts of others? Am I being too hard on management?

Expand

January is a dead quiet month for selling anything so now we’re into February, I’d say you’ll see some sales start to happen. It’s also not selling widgets or second hand cars. This is a 850k per full treatment big ticket item. Big sales take time. Be patient dude!

MSB Price at posting: $2.78 Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 31 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.65		Change 0.030(1.85%)		Mkt cap ! $2.108B

Open	High	Low	Value	Volume
$1.64	$1.67	$1.63	$4.884M	2.962M

Buyers (Bids)

No.	Vol.	Price($)
3	10583	$1.65

Sellers (Offers)

Price($)	Vol.	No.
$1.66	16415	4

View Market Depth

No.	Vol.	Price($)
3	10583	1.650
2	23000	1.645
4	27999	1.640
1	876	1.635
4	18446	1.630

Price($)	Vol.	No.
1.660	10415	2
1.665	30000	2
1.670	16598	2
1.675	4000	1
1.680	17509	4

Last trade - 16.12pm 27/06/2025 (20 minute delay)

MSB (ASX) Chart

Ann: Ryoncil Highlighted at Tandem Transplantation Meetings, page-31

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Ryoncil Highlighted at Tandem Transplantation Meetings, page-31

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News